MUSC Children's Hospital MUSC Children's Hospital
  We're all about children!

  Home
  About Us
  Divisions
  Ask a Med-U-Nurse
  Health Library
  Find a Doctor
  For Physicians
  Job Opportunities
  Make a Difference
  News & Events
   News Room
   Kids Connection Newsletter
   Support Groups
   Special Events
   Parenting Newsletter
   Parenting Classes
   Community Classes
   Grand Rounds Schedule

  Research
  Residents & Fellows
  Your Hospital Visit



171 Ashley Ave.
Charleston, SC 29425
843-792-1414
800-424-MUSC


printPrint Version

Kids Connection Newsletter
February 2009
Children's Research Institute News Brief

Research on Renal Disease Progresses

In Dr. Darwin Bell's Laboratory of Renal Biology in the Darby Children's Research Institute, 12 researchers are intent on making sure kids like Ashley Jennings (see feature story, above) are spared the agony of polycystic kidney disease (PKD).

The lab, which focuses on PKD, has made significant progress in the last couple of years, expanding its ongoing research to develop and characterize mouse models with features that mirror almost exactly the human form of the disease, says Dr. Bell, who is director of renal research for the Division of Nephrology.

"That's allowed us to identify a combination of two cell membrane proteins which, when genetically modified, may play a central role in PKD," explains Dr. Bell. The research team is currently performing high throughput screening in an effort to discover pharmaceutical agents that block this protein complex. By blocking this complex, the hope is that it will ameliorate or slow the progression of cyst formation.

PKD is the most prevalent and life-threatening of genetic disorders, affecting more than 600,000 Americans. The disease has two forms - autosomal dominant PKD is the most common, affecting about one in 500 adults. Recessive PKD (which is what Jennings has) is less common, but affects newborns, infants and children, having a devastating effect on their kidneys and other organs.

The disorder causes multiple cysts in each kidney to grow and multiply over time, resulting in kidney enlargement. Ultimately the diseased kidney shuts down, making dialysis and transplantation the only forms of treatment.

Clinical trials are on the horizon, says Dr. Bell.

"The goal is to identify and design the therapeutic agents that will inhibit cyst formation in mouse models of PKD, and ultimately to extend this research into human clinical trails," says Dr. Bell.


Inderjit Singh, PhD Inderjit Singh, PhD
Scientific Director
Darby Children's Research Inst.
Dr. Maria Bernard L. Maria, MD, MBA
Executive Director
Darby Children's Research Inst.


Terms and Conditions | Privacy Policy | Site Map | Contact Us